Overview of Zika infection, epidemiology, transmission and control measures

Journal of Infection and Public Health

Volumn 10, Issue 2, 2017, Pages 141-149

  Rabaan, Ali A ^a   Bazzi, Ali M ^a   Al Ahmed, Shamsah H ^b   Al Ghaith, Mohamed H ^a   Al Tawfiq, Jaffar A ^a,c  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

^b QATIF CENTRAL HOSPITAL   (Saudi Arabia)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Control measures; Diagnostic test; Epidemiology; Transmission; Zika infection; ZIKV

Indexed keywords

ANTIVIRUS AGENT; ZIKA VIRUS VACCINE;

ANTIVIRAL THERAPY; BED NET; HISTORY OF MEDICINE; HUMAN; INFECTION CONTROL; MOSQUITO CONTROL; NONHUMAN; PRIORITY JOURNAL; PROTECTIVE CLOTHING; REVIEW; SYMPTOM; VIROLOGY; VIRUS TRANSMISSION; ZIKA FEVER; AEDES; ANIMAL; COMMUNICABLE DISEASE CONTROL; COMPLICATION; DISEASE TRANSMISSION; GROWTH, DEVELOPMENT AND AGING; HEALTH; INSECT VECTOR; MICROCEPHALY; PREVENTION AND CONTROL; PROCEDURES; TRANSMISSION; ZIKA VIRUS INFECTION;

AEDES; ANIMALS; COMMUNICABLE DISEASE CONTROL; DISEASE TRANSMISSION, INFECTIOUS; GLOBAL HEALTH; HUMANS; INSECT VECTORS; MICROCEPHALY; ZIKA VIRUS INFECTION;

EID: 85015355571     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2016.05.007     Document Type: Review

References (50)

1. [1] World Health Organization [WHO]. Zika situation report. Neurological syndrome and congenital abnormalities 2016 5 February http://www.who.int/emergencies/zika-virus/situation-report/5-february-2016/en/ [accessed 23.02.16]; 2016.
2. [2] Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Velez, J.O., Lambert, A.J., Johnson, A.J., et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:8 (2008), 1232–1239.
3. [3] Musso, D., Roche, C., Robin, E., Nhan, T., Teissier, A., Cao-Lormeau, V.M., Potential sexual transmission of Zika virus. Emerg Infect Dis 21:2 (2015), 359–361.
4. [4] Besnard, M., Lastere, S., Teissier, A., Cao-Lormeau, V., Musso, D., Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill, 19(13), 2014, 20751.
5. [5] Musso, D., Nhan, T., Robin, E., Roche, C., Bierlaire, D., Zisou, K., et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill, 19(14), 2014, 20761.
6. [6] Petersen, E., Wilson, M.E., Touch, S., McCloskey, B., Mwaba, P., Bates, M., et al. Rapid Spread of Zika Virus in The Americas — Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games. Int J Infect Dis 44 (2016), 11–15.
7. [7] Elachola, H., Gozzer, E., Zhuo, J., Memish, Z.A., A crucial time for public health preparedness: Zika virus and the 2016 Olympics, Umrah, and Hajj. Lancet 387:10019 (2016), 630–632.
8. [8] Duffy, M.R., Chen, T.H., Hancock, W.T., Powers, A.M., Kool, J.L., Lanciotti, R.S., et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360:24 (2009), 2536–2543.
9. [9] Musso, D., Roche, C., Nhan, T.X., Robin, E., Teissier, A., Cao-Lormeau, V.M., Detection of Zika virus in saliva. J Clin Virol 68 (2015), 53–55.
10. [10] European Centre for Disease Protection Control [ECDC]. Rapid Risk Assessment. Zika virus infection outbreak Brazil and the Pacific region- 25 May Stockholm: ECDC, http://ecdc.europa.eu/en/publications/Publications/rapid-risk-assessment-Zika%20virus-south-america-Brazil-2015.pdf [accessed 23.02.16]; 2015.
11. [11] Centers for Disease Control and Prevention [CDC]. Zika Virus, http://www.cdc.gov/zika/index.html [accessed 04.04.16]; 2016.
12. [12] Dick, G.W., Kitchen, S.W., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 46:5 (1952), 509–520.
13. [13] Dick, G.W., Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg 46:5 (1952), 521–534.
14. [14] Ledermann, J.P., Guillaumot, L., Yug, L., Saweyog, S.C., Tided, M., Machieng, P., et al. Aedes hensilli as a potential vector of Chikungunya and Zika viruses. PLoS Negl Trop Dis, 8(10), 2014, e3188.
15. [15] Diallo, D., Sall, A.A., Diagne, C.T., Faye, O., Faye, O., Ba, Y., et al. Zika virus emergence in mosquitoes in southeastern Senegal, 2011. PLoS One, 9(10), 2014, e109442.
16. [16] Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastere, S., Valour, F., et al. Zika virus infection complicated by Guillain-Barre syndrome—case report, French Polynesia, December 2013. Euro Surveill, 19(9), 2014, 20720.
17. [17] Ioos, S., Mallet, H.P., Leparc Goffart, I., Gauthier, V., Cardoso, T., Herida, M., Current Zika virus epidemiology and recent epidemics. Med Mal Infect 44:7 (2014), 302–307.
18. [18] Cao-Lormeau, V.M., Roche, C., Teissier, A., Robin, E., Berry, A.L., Mallet, H.P., et al. Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis 20:6 (2014), 1085–1086.
19. [19] Musso, D., Cao-Lormeau, V.M., Gubler, D.J., Zika virus: following the path of dengue and chikungunya?. Lancet 386:9990 (2015), 243–244.
20. [20] Kuno, G., Chang, G.J., Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol 152:4 (2007), 687–696.
21. [21] Haddow, A.D., Schuh, A.J., Yasuda, C.Y., Kasper, M.R., Heang, V., Huy, R.G., et al. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis, 6(2), 2012, e1477.
22. [22] Petersen, E.E., Staples, J.E., Meaney-Delman, D., Fischer, M., Ellington, S.R., Callaghan, W.M., et al. Interim guidelines for pregnant women during a Zika virus outbreak - United States, 2016. MMWR Morb Mortal Wkly Rep 65:2 (2016), 30–33.
23. [23] Hayes, E.B., Zika virus outside Africa. Emerg Infect Dis 15:9 (2009), 1347–1350.
24. [24] Centers for Disease Control and Prevention [CDC]. Japanese Encephalitis, http://www.cdc.gov/japaneseencephalitis/ [accessed 23.02.16]; 2015.
25. [25] Mlakar, J., Korva, M., Tul, N., Popović, M., Poljšak-Prijatelj, M., Mraz, J., et al. Zika virus associated with microcephaly. N Engl J Med(February), 2016 [Epub ahead of print].
26. [26] Rubin, E.J., Greene, M.F., Baden, L.R., Zika virus and microcephaly. N Engl J Med(February), 2016 [Epub ahead of print].
27. [27] Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N., et al. Biology of Zika virus infection in human skin cells. J Virol 89:17 (2015), 8880–8896.
28. [28] Pyke, A.T., Daly, M.T., Cameron, J.N., Moore, P.R., Taylor, C.T., Hewitson, G.R., et al. Imported Zika virus infection from the Cook Islands into Australia, 2014. PLoS Curr, 2014, 6 pii: ecurrents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e.
29. [29] Fonseca, K., Meatherall, B., Zarra, D., Drebot, M., MacDonald, J., Pabbaraju, K., et al. First case of Zika virus infection in a returning Canadian traveler. Am J Trop Med Hyg 91:5 (2014), 1035–1038.
30. [30] Maria, A.T., Maquart, M., Makinson, A., Flusin, O., Segondy, M., Leparc-Goffart, I., et al. Zika virus infections in three travellers returning from South America and the Caribbean respectively, to Montpellier, France, December 2015 to January 2016. Euro Surveill, 21(6), 2016, 10.2807/1560-7917.ES.2016.21.6.30131.
31. [31] Zammarchi, L., Tappe, D., Fortuna, C., Remoli, M.E., Günther, S., Venturi, G., et al. Zika virus infection in a traveller returning to Europe from Brazil, March 2015. Euro Surveill, 20(23), 2015, 21153.
32. [32] Zammarchi, L., Stella, G., Mantella, A., Bartolozzi, D., Tappe, D., Günther, S., et al. Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications. J Clin Virol 63 (2015), 32–35.
33. [33] Tappe, D., Rissland, J., Gabriel, M., Emmerich, P., Gunther, S., Held, G., et al. First case of laboratory-confirmed Zika virus infection imported into Europe, November 2013. Euro Surveill, 19(4), 2014, 20685.
34. [34] Foy, B.D., Kobylinski, K.C., Chilson Foy, J.L., Blitvich, B.J., Travassos da Rosa, A., Haddow, A.D., et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 17:5 (2011), 880–882.
35. [35] Venturi, G., Zammarchi, L., Fortuna, C., Remoli, M.E., Benedetti, E., Fiorentini, C., et al. An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014. Euro Surveill, 21(8), 2016, 10.2807/1560-7917.ES.2016.21 8.30148.
36. [36] Hills, S.L., Russell, K., Hennessey, M., Williams, C., Oster, A.M., Fischer, M., et al. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission - continental United States, 2016. MMWR Morb Mortal Wkly Rep 65:8 (2016), 215–216.
37. [37] World Health Organization [WHO]. Mosquito control: can it stop Zika at source? http://www.who.int/emergencies/zika-virus/articles/mosquito-control/en/ [accessed 23.02.16]; 2016.
38. [38] Mackenzie, J.S., Williams, D.T., The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses. Zoonoses Public Health 56:6–7 (2009), 338–356.
39. [39] Carvalho, D.O., McKemey, A.R., Garziera, L., Lacroix, R., Donnelly, C.A., Alphey, L., et al. Suppression of a field population of Aedes aegypti in Brazil by sustained release of transgenic male mosquitoes. PLoS Negl Trop Dis, 9(7), 2015, e0003864.
40. [40] Robinson, A.S., Knols, B.G., Voigt, G., Hendrichs, J., Conceptual framework and rationale. Malar J, 8(Suppl 2), 2009, S1.
41. [41] Ageep, T.B., Damiens, D., Alsharif, B., Ahmed, A., Salih, E.H., Ahmed, F.T., et al. Participation of irradiated Anopheles arabiensis males in swarms following field release in Sudan. Malar J, 13, 2014, 484.
42. [42] Joubert, D.A., Walker, T., Carrington, L.B., De Bruyne, J.T., Kien, D.H., Hoang Nle, T., et al. Establishment of a Wolbachia Superinfection in Aedes aegypti Mosquitoes as a potential approach for future resistance management. PLoS Pathog, 12(2), 2016, e1005434.
43. [43] Ramirez, J.L., Short, S.M., Bahia, A.C., Saraiva, R.G., Dong, Y., Kang, S., et al. Chromobacterium Csp_P reduces malaria and dengue infection in vector mosquitoes and has entomopathogenic and in vitro anti-pathogen activities. PLoS Pathog, 10(10), 2014, e3981004.
44. [44] Galizi, R., Doyle, L.A., Menichelli, M., Bernardini, F., Deredec, A., Burt, A., et al. A synthetic sex ratio distortion system for the control of the human malaria mosquito. Nat Commun, 5, 2014, 3977.
45. [45] Faye, O., Faye, O., Dupressoir, A., Weidmann, M., Ndiaye, M., Alpha Sall, A., One-step RT-PCR for detection of Zika virus. J Clin Virol 43:1 (2008), 96–101.
46. [46] Balm, M.N., Lee, C.K., Lee, H.K., Chiu, L., Koay, E.S., Tang, J.W., A diagnostic polymerase chain reaction assay for Zika virus. J Med Virol 84:9 (2012), 1501–1505.
47. [47] Gourinat, A.C., O'Connor, O., Calvez, E., Goarant, C., Dupont-Rouzeyrol, M., Detection of Zika virus in urine. Emerg Infect Dis 21:1 (2015), 84–86.
48. [48] EUROIMMUN UK. First commercial antibody tests for Zika virus diagnostics, https://www.euroimmun.co.uk/recent-news/first-commercial-antibody-tests-for-zika-virus-diagnostics [accessed 04.04.16].
49. [49] Invovio. Inovio Pharmaceutical's DNA Vaccine for Zika Virus Induces Robust Immune Responses in Preclinical Study, http://ir.inovio.com/news/news-releases/news-releases-details/2016/Inovio-Pharmaceuticals-DNA-Vaccine-for-Zika-Virus-Induces-Robust-Immune-Responses-in-Preclinical-Study/default.aspx [accessed 23.02.16]; 2016.
50. [50] Science Alert. An Indian company says they have two Zika vaccine candidates ready for pre-clinical trials, http://www.sciencealert.com/an-indian-company-says-they-have-2-zika-vaccines-ready-for-pre-clinical-trials/ [accessed 23.02.16]; 2016.